Ftse Mib
36.719,35
1,38%
DAX
21.505,70
0,47%
S&P 500
6.037,88
0,72%
NASDAQ
19.654,02
1,35%
Bitcoin
98.132,08
0,28%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Newellis Inc (NUWE) Newellis Inc (NUWE) Notizie

Newellis Inc

NUWE
1,24
0,03 (2,48%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 00:56:30
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/1/202514:00GLOBENuwellis Adds Nationally Ranked Utah Hospital as New..
19/12/202415:00GLOBENuwellis Regains Compliance with Nasdaq Listing Requirements
20/11/202419:29EDGAR2Form D - Notice of Exempt Offering of Securities
11/11/202414:00GLOBENuwellis, Inc. Announces Third Quarter 2024 Financial..
11/11/202412:04IHMARKETNEWSTesla Rises 5% Pre-Market After Surpassing $1T Market Value;..
05/11/202415:28GLOBENuwellis Announces Exercise of Warrants for $5.1 Million of..
04/11/202414:30GLOBENuwellis Receives Increased Reimbursement Rate for Aquadex..
01/11/202421:15GLOBENuwellis Announces Preliminary Results for Third Quarter of..
31/10/202413:00GLOBENuwellis Welcomes University of Iowa Health Care Stead..
23/10/202422:15GLOBENuwellis, Inc. To Report Third Quarter 2024 Financial..
25/9/202422:15GLOBENuwellis to Present at the Third Annual ROTH Healthcare..
30/8/202422:11EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
27/8/202415:00GLOBENew Study Published in Current Problems in Cardiology..
26/8/202422:45EDGAR2Form 8-K - Current report
24/8/202403:31EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
23/8/202415:00GLOBENuwellis Announces Pricing of $916,000 Registered Direct..
13/8/202423:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202419:00EDGAR2Form 8-K - Current report
13/8/202414:00GLOBENuwellis, Inc. Announces Second Quarter 2024 Financial..
12/8/202415:15EDGAR2Form 8-K - Current report
08/8/202415:00GLOBENasdaq Panel Grants Nuwellis Continued Listing on the Nasdaq..
02/8/202422:12EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
26/7/202415:00GLOBENuwellis Announces First Pediatric Patient Treated in a..
25/7/202415:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
25/7/202414:31EDGAR2Form 8-K - Current report
24/7/202414:02GLOBENuwellis Announces Pricing of $2.0 Million Offering Priced..
23/7/202422:10GLOBENuwellis, Inc. To Report Second Quarter 2024 Financial..
17/7/202422:01EDGAR2Form 8-K/A - Current report: [Amend]
17/7/202415:12EDGAR2Form 8-K - Current report
17/7/202415:00GLOBENuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy..
12/7/202414:30GLOBESeaStar Medical Ships First QUELIMMUNE Product Order to U.S...
09/7/202415:00GLOBENew Evidence on Aquadex Ultrafiltration Therapy to be..
26/6/202414:45GLOBENuwellis Announces Reverse Stock Split
25/6/202415:00GLOBENuwellis Secures New Patent for Innovative Pediatric..
10/6/202422:15EDGAR2Form 8-K - Current report
06/6/202415:15EDGAR2Form 8-K - Current report
06/6/202415:00GLOBENuwellis and DaVita Extend Supply and Collaboration..
29/5/202417:54EDGAR2Form SD - Specialized disclosure report
17/5/202423:20EDGAR2Form DEFR14A - Revised definitive proxy soliciting materials
14/5/202415:00GLOBENuwellis Announces Expansion of Ultrafiltration Program to..
09/5/202415:00GLOBENuwellis Announces Purchase Agreement with a 50 Hospital..
08/5/202423:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202423:26EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
07/5/202414:00GLOBENuwellis, Inc. Announces First Quarter 2024 Financial..
02/5/202415:00GLOBENuwellis Receives USPTO Notice of Patent Allowance for..
01/5/202400:09GLOBENuwellis Announces Closing of $2.7 Million Public Offering
30/4/202422:41GLOBENuwellis, Inc. To Report First Quarter 2024 Financial..
26/4/202415:17GLOBENuwellis Announces Pricing of $2.7 Million Public Offering
09/4/202415:00GLOBENuwellis Announces Launch of Ultrafiltration Therapy Using..
11/3/202422:08EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
Apertura: 1,20 Min: 1,19 Max: 1,25
Chiusura: 1,21

La tua Cronologia

NASDAQ
NUWE
Newellis
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci